Torrent Pharmaceuticals Limited
TORNTPHARM
Classifica tra le azioni
#1201
Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity,... Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity, managing the entire process from the discovery and development of generic drug formulations to their production and distribution. Its commercial activities extend across key markets such as India, the United States, Germany, and Brazil, alongside various other international territories. The company boasts a broad product catalog, offering treatments for a wide array of medical conditions. This includes therapies for cardiovascular diseases, central nervous system disorders, gastrointestinal issues, women's health concerns, diabetes, pain management, gynecological ailments, oncology, and anti-infective medications. Additionally, Torrent Pharma supplies essential vitamins, minerals, and other nutritional supplements. Beyond its proprietary offerings, the firm also provides contract manufacturing services to other companies. During the COVID-19 pandemic, it demonstrated its commitment by securing licensing agreements for crucial treatments like Baricitinib, Molnupiravir, and Paxlovid. Established in 1959, the company originally operated under the name Trinity Laboratories before officially becoming Torrent Pharmaceuticals Limited in 1971. Its corporate headquarters are located in Ahmedabad, India. Ultimately, Torrent Pharmaceuticals Limited functions as a subsidiary of Torrent Investments Private Limited.
Prezzo delle azioni
$50.31
Ultima sincronizzazione: 2026-10-19
Capitalizzazione di mercato
$19.14B
Variazione (1 giorno)
-0.14%
Variazione (1 anno)
23.83%
Paese
IN
Scambia Torrent Pharmaceuticals Limited (TORNTPHARM)
Categoria
Healthcare
Rapporto P/B per Torrent Pharmaceuticals Limited (TORNTPHARM)
Rapporto P/B al October 2026 TTM: 8.89
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Torrent Pharmaceuticals Limited, il rapporto P/B attuale (TTM) è 8.89. Alla fine del 2024, era pari a 13.21.
Storico del rapporto P/B per Torrent Pharmaceuticals Limited da 2005 a 2026
Rapporto P/B alla fine di ogni anno
| Anno | Rapporto P/B | Cambia |
|---|---|---|
| 2026 (TTM) | 8.89 | -37.38% |
| 2025 | 14.19 | 7.48% |
| 2024 | 13.21 | 57.34% |
| 2023 | 8.39 | 5.76% |
| 2022 | 7.94 | 7.57% |
| 2021 | 7.38 | 6.65% |
| 2020 | 6.92 | 1.65% |
| 2019 | 6.81 | 46.79% |
| 2018 | 4.64 | -23.24% |
| 2017 | 6.04 | -9.75% |
| 2016 | 6.69 | -14.99% |
| 2015 | 7.87 | 68.81% |
| 2014 | 4.66 | 14.99% |
| 2013 | 4.06 | -9.26% |
| 2012 | 4.47 | -6.96% |
| 2011 | 4.80 | -13.51% |
| 2010 | 5.55 | 218.83% |
| 2009 | 1.74 | -25.49% |
| 2008 | 2.34 | -42.11% |
| 2007 | 4.04 | -23.55% |
| 2006 | 5.28 | 77.99% |
| 2005 | 2.97 | 0.00% |
Rapporto P/B per aziende simili o concorrenti
| Azienda | Rapporto P/B | Differenza del rapporto P/B | Il paese |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -43.26% |
IN
|
